|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 9/24 | |
| C12N 1/20 | |||
| C12N 15/00 | |||
| C07H 21/04 | |||
| A61K 38/47 | |||
| A61K 38/00 | |||
| A61K 39/00 |
| (11) | Patento numeris | 3018204 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15180371.5 |
| Europos patento paraiškos padavimo data | 2005-07-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-05-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-04-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 939262 | 2004-09-10 | US |
| (72) |
FANG, Fang, US
MALAKHOV, Michael, US
|
| (73) |
Ansun Biopharma, Inc.,
3030 Callan Road, San Diego CA 92121,
US
|
| (54) | A NOVEL CLASS OF THERAPEUTIC PROTEIN BASED MOLECULES |
| A NOVEL CLASS OF THERAPEUTIC PROTEIN BASED MOLECULES |